Onco-Life Scientific Evening Showcases Emerging Technologies and Collaborative Cancer Care

IMT News Desk
IMT News Desk
· 3 min read
Onco-Life’s Doctors’ Scientific Evening in Pune spotlighted emerging oncology technologies, multidisciplinary cancer care and collaboration beyond the clinic.

Onco-Life Cancer Centre recently organised an exclusive Doctors’ Scientific Evening, bringing together oncologists, surgeons, radiation specialists, physicians and other healthcare professionals for a programme dedicated to scientific learning, multidisciplinary collaboration and professional networking. The event combined academic sessions, technology updates and informal interactions, offering a platform for cancer specialists to exchange knowledge on emerging therapies while also fostering camaraderie beyond the clinical setting.

The academic programme highlighted several important developments in oncology, including the role of Helical TomoTherapy in managing complex and challenging cancer cases and recent progress in precision oncology, immunotherapy and targeted therapy. Experts also discussed modern surgical approaches such as organ preservation strategies, HIPEC and multidisciplinary treatment planning, underscoring the need for coordinated care to improve patient outcomes. A panel discussion on the future of multidisciplinary cancer care enabled specialists from different fields to share perspectives on delivering comprehensive, evidence-based treatment, and the evening concluded with an interactive question-and-answer session and closing remarks.

The event featured a special scientific presentation by Elekta showcasing recent advancements in Online Adaptive Technology and its role in improving precision radiation therapy. Online adaptive radiotherapy allows clinicians to adjust treatment plans in real time based on the patient’s anatomy at the time of treatment, helping to better target tumours while sparing healthy tissue and enhancing the personalisation of cancer care. Following the academic sessions, participating doctors joined a networking segment that encouraged meaningful interactions and the exchange of clinical experiences across specialties.

“Cancer care is advancing rapidly, and continuous scientific learning is essential to ensure patients receive the most appropriate and evidence-based treatment,” said Mr Uday Deshmukh, Chairman and Founder CEO of Onco-Life Cancer Centre. He emphasised that meetings of this kind allow specialists from different disciplines to discuss emerging therapies, exchange clinical experiences and work towards more collaborative cancer management, ultimately translating into better treatment planning and improved outcomes for patients.

“Our objective was to create a platform where scientific discussions, technological advancements and multidisciplinary collaboration could come together in one setting,” added Mr Sachin Deshmukh, Managing Director. He noted that it was equally important to give doctors an opportunity to connect beyond their clinical responsibilities, strengthen professional relationships and continue building a collaborative healthcare ecosystem that benefits both clinicians and patients.

The scientific evening reflects Onco-Life Cancer Centre’s ongoing commitment to promoting oncology education, encouraging multidisciplinary collaboration and supporting continuous medical learning to enhance the overall quality of cancer care.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk